Sale!

Immunohistochemistry Breast Cancer Panel 2 Test

960 د.إ

-10%

The “Immunohistochemistry Breast Cancer Panel 2 Test,” available at DNA Labs UAE for 960 AED, is a specialized diagnostic tool used in the evaluation and management of breast cancer. This test employs immunohistochemistry (IHC) techniques to detect the presence and quantify the expression levels of specific protein markers in breast tissue samples. These markers are crucial for understanding the biological behavior of the cancer, predicting its aggressiveness, and determining the most effective treatment strategies.

By targeting a panel of biomarkers specifically chosen for their relevance in breast cancer, the test provides comprehensive insights into the tumor’s characteristics. This information is invaluable for tailoring treatment plans to the individual patient, potentially improving outcomes by selecting therapies that are more likely to be effective based on the tumor’s profile.

DNA Labs UAE, known for its commitment to precision and accuracy in diagnostic services, offers this test at a cost of 960 AED. The facility ensures that the testing process, from sample collection to analysis and reporting, is conducted according to the highest standards of quality and reliability. This test is an essential component of modern breast cancer care, facilitating a more personalized approach to treatment and management of the disease.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

IMMUNOHISTOCHEMISTRY BREAST CANCER PANEL 2 Test

Test Name: IMMUNOHISTOCHEMISTRY BREAST CANCER PANEL 2 Test

Test Components:

  • ER
  • PR
  • Cathepsin D
  • Includes pathologist review for presence of malignant cells

Price: 960.0 AED

Sample Condition: Submit tumor tissue in 10% Formal-saline or Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Clinical history & indicate site of biopsy.

Report Delivery:

  • Sample: Daily by 6 pm
  • Report – Block: 5 days
  • Tissue biopsy: 5 days
  • Tissue large complex: 7 days

Method: Immunohistochemistry

Test Type: Cancer

Doctor: Oncologist

Test Department: HISTOLOGY

Pre Test Information: Provide a copy of the Histopathology report, Clinical history & indicate site of biopsy.

Test Details

The IMMUNOHISTOCHEMISTRY BREAST CANCER PANEL 2 test is a diagnostic tool used to identify specific proteins or biomarkers in breast cancer tissue samples. This panel typically includes a combination of different antibodies that target markers commonly associated with breast cancer, such as estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67.

The ER and PR markers are hormone receptors that indicate whether the cancer cells are dependent on estrogen or progesterone for growth. HER2 is a protein that promotes the growth of cancer cells and is overexpressed in about 20% of breast cancer cases. Ki-67 is a protein associated with cell proliferation and is used as a marker of tumor aggressiveness.

By analyzing the expression of these markers through immunohistochemistry, pathologists can determine the molecular subtype of breast cancer, which helps guide treatment decisions. For example, patients with ER-positive breast cancer may benefit from hormonal therapies, while those with HER2-positive breast cancer may be eligible for targeted therapies such as trastuzumab.

Overall, the IMMUNOHISTOCHEMISTRY BREAST CANCER PANEL 2 test provides important information about the molecular characteristics of breast cancer, helping clinicians tailor treatment plans to each patient’s specific needs.

Test Name IMMUNOHISTOCHEMISTRY BREAST CANCER PANEL 2 Test
Components *ER*PR*Cathepsin D *Includes pathologist review for presence of malignant cells
Price 960.0 AED
Sample Condition Submit tumor tissue in 10% Formal-saline \nOR Formalin fixedparaffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Clinical history & indicate site of biopsy.
Report Delivery Sample Daily by 6 pm; Report – Block : 5 days Tissue biopsy : 5 days Tissue large complex : 7 days
Method Immunohistochemistry
Test type Cancer
Doctor Oncologist
Test Department: HISTOLOGY
Pre Test Information Provide a copy of the Histopathology report, Clinical history & indicate site of biopsy.
Test Details

The IMMUNOHISTOCHEMISTRY BREAST CANCER PANEL 2 test is a diagnostic tool used to identify specific proteins or biomarkers in breast cancer tissue samples. This panel typically includes a combination of different antibodies that target markers commonly associated with breast cancer, such as estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67.

The ER and PR markers are hormone receptors that indicate whether the cancer cells are dependent on estrogen or progesterone for growth. HER2 is a protein that promotes the growth of cancer cells and is overexpressed in about 20% of breast cancer cases. Ki-67 is a protein associated with cell proliferation and is used as a marker of tumor aggressiveness.

By analyzing the expression of these markers through immunohistochemistry, pathologists can determine the molecular subtype of breast cancer, which helps guide treatment decisions. For example, patients with ER-positive breast cancer may benefit from hormonal therapies, while those with HER2-positive breast cancer may be eligible for targeted therapies such as trastuzumab.

Overall, the IMMUNOHISTOCHEMISTRY BREAST CANCER PANEL 2 test provides important information about the molecular characteristics of breast cancer, helping clinicians tailor treatment plans to each patient’s specific needs.